1-hydroxyadamantan-4-one,
ADK-412,
kamantane,
kemantan,
kemantane,
5-Hydroxyadamantan-2-one,
Idramantone,
20098-14-0,
5-Hydroxy-2-adamantanone,
Kemantane,
5-Hydroxy-adamantan-2-one,
UNII-7J4759Y5J1,
CHEBI:48581,
TZBDEVBNMSLVKT-UHFFFAOYSA-N,
7J4759Y5J1,
5-hydroxytricyclo[3.3.1.1(3,7)]decanone,
Tricyclo[3.3.1.13,7]decanone, 5-hydroxy-,
Idramantone [INN],
Tricyclo(3.3.1.13,7)decanone, 5-hydroxy-,
kemantan,
5-Hydroxy-2-adamantanone, 98%,
NCGC00166261-01,
4-oxo-1-adamantanol,
4-oxoadamantan-1-ol,
5-hydroxy adamantanone,
Adamantan-4-on-1-ol,
5-hydroxy-2-admantanone,
5-Hydroxyadmantan-2-one,
1-hydroxy-4-adamantanone,
5-hydroxyadamantane-2-on,
ACMC-1CO9N,
1-hydroxyadamantane-4-one,
5-hydroxy -2-adamantanone,
AC1L20MI,
DSSTox_CID_26581,
DSSTox_RID_81740,
DSSTox_GSID_46581,
Oprea1_254797,
SCHEMBL61676,
KSC201Q6R,
AC1Q79E3,
CHEMBL2105062,
DTXSID8046581,
SCHEMBL19309631,
CTK1A1868,
HMS3264D04,
Pharmakon1600-01506164,
ACT03088,
ALBB-013713,
HY-B1044,
KS-00000F5Z,
Tox21_112380,
ANW-23912,
FC0707,
GEO-01502,
NSC760375,
s4529,
SBB017535,
AKOS001031795,
AKOS016038251,
AM84690,
CCG-213971,
CS-4565,
MCULE-5825722771,
NSC-760375,
RTR-009356,
AC-24311,
AK-68405,
AS-12160,
BC682492,
BR-68405,
SY032209,
AB0011421,
AB1008053,
CAS-20098-14-0,
DB-025390,
TR-009356,
4-Bromo-10-oxido-1-phenazinyl methyl ether,
4CH-018064,
BB 0237254,
FT-0659076,
ST50926184,
EN300-54117,
MFCD00192211 (98%),
5-hydroxytricyclo[3.3.1.13,7 ]decan-2-one,
M-2888,
AB01563368_01,
AE-641/20320060,
SR-01000944271,
Tricyclo[3.3.1.13,7]decan-2-one, 5-hydroxy-,
I14-1852,
SR-01000944271-1,
tricyclo[3.3.1.1~3,7~]decan-2-one, 5-hydroxy-,
null,
5-Hydroxy-2-adamantone,
C10H14O2,
CID64184,
1-Bromo-4-methoxyphenazine 5-oxide,
c0607,
MFCD00192211,
ACN-037059,
C10-H14-O2,
5-Hydroxy-2-adamantanone, 98% 250mg,
1-[2-(methylthio)ethyl]-4-piperidinamine,
5-Hydroxy-2-adamantanone, 98% - 1G 1g,
H0962,
A15355,